Expand BCTX Menu
BCTX MENU

BCTX Latest Press Releases

-- January 27, 2025 --

BriaCell Announces Completion of 15:1 Share Consolidation Globe Newswire 6:42 PM

-- January 3, 2025 --

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025 Globe Newswire 5:05 PM
BriaCell Announces Proposed Effective Date of Share Consolidation Globe Newswire 5:05 PM

-- December 17, 2024 --

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures Globe Newswire 4:06 PM
BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures Globe Newswire 4:05 PM

-- December 13, 2024 --

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering Globe Newswire 4:05 PM
BriaCell 2024 SABCS Poster Highlights Ability of Bria-IMT Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer Globe Newswire 7:50 AM

-- December 11, 2024 --

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering Globe Newswire 11:54 PM
BriaCell Therapeutics Announces Proposed Public Offering Globe Newswire 4:05 PM
BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS Globe Newswire 7:50 AM

-- December 2, 2024 --

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer Globe Newswire 7:50 AM

-- November 26, 2024 --

BriaCell 2024 SABCS Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer Globe Newswire 7:50 AM

-- November 25, 2024 --

BriaCell Provides Update to its Board of Directors Globe Newswire 7:50 AM

-- November 21, 2024 --

BriaCell Announces First Patient Dosed with Bria-OTS in Metastatic Breast Cancer Study Globe Newswire 7:50 AM

-- November 8, 2024 --

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference Globe Newswire 7:50 AM

-- November 4, 2024 --

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium, December 10 13 Globe Newswire 7:50 AM

-- October 22, 2024 --

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data Globe Newswire 7:50 AM

-- October 15, 2024 --

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study Globe Newswire 7:50 AM

-- October 2, 2024 --

BriaCell Therapeutics Announces Closing of $5 Million Offering Globe Newswire 4:05 PM

-- October 1, 2024 --

BriaCell Therapeutics Announces $5 Million Offering Globe Newswire 2:05 PM
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with "Eye-Bulging" Tumor Globe Newswire 7:50 AM

-- September 18, 2024 --

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients Globe Newswire 7:50 AM

-- September 12, 2024 --

BriaCell Therapeutics Announces Closing of $8.5 Million Offering Globe Newswire 4:05 PM

-- September 11, 2024 --

BriaCell Therapeutics Announces $8.5 Million Offering Globe Newswire 12:09 PM
BriaCell Reports Positive Overall Survival (OS) in Metastatic Breast Cancer Globe Newswire 7:50 AM

-- September 10, 2024 --

BriaCell Announces Positive Pre-IND Meeting with FDA for Bria-PROS+ for Prostate Cancer Globe Newswire 7:50 AM

-- September 9, 2024 --

BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting Globe Newswire 7:50 AM